# EDGAR Filing Document

**Accession Number:** 0001944885
**File Stem:** 0001213900-25-085030
**Filing Date:** 2025-9
**Character Count:** 10621
**Document Hash:** 143d86e2b7e4df6d9f863ca814db38c6
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001213900-25-085030.hdr.sgml**: 20250905

**ACCESSION NUMBER**: 0001213900-25-085030

**CONFORMED SUBMISSION TYPE**: SCHEDULE 13G/A

**PUBLIC DOCUMENT COUNT**: 1

**FILED AS OF DATE**: 20250905

**DATE AS OF CHANGE**: 20250905

**SUBJECT COMPANY**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Apollomics Inc.
- **CENTRAL INDEX KEY:** 0001944885
- **STANDARD INDUSTRIAL CLASSIFICATION:** PHARMACEUTICAL PREPARATIONS [2834]
- **ORGANIZATION NAME:** 03 Life Sciences
- **EIN:** 000000000
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** SCHEDULE 13G/A
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 005-94041
- **FILM NUMBER:** 251296922

**BUSINESS ADDRESS:**
- **STREET 1:** 989 EAST HILLSDALE BLVD.
- **STREET 2:** STE 220
- **CITY:** FOSTER CITY
- **STATE:** CA
- **ZIP:** 94404
- **BUSINESS PHONE:** 1-650-209-4055

**MAIL ADDRESS:**
- **STREET 1:** 989 EAST HILLSDALE BLVD.
- **STREET 2:** STE 220
- **CITY:** FOSTER CITY
- **STATE:** CA
- **ZIP:** 94404
**FILED BY**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Maxpro Investment Co., Ltd
- **CENTRAL INDEX KEY:** 0002023743

**ORGANIZATION NAME:**
- **EIN:** 000000000

**FILING VALUES:**
- **FORM TYPE:** SCHEDULE 13G/A

**BUSINESS ADDRESS:**
- **STREET 1:** NO.89, SONGREN RD., XINYI DIST.
- **CITY:** TAIPEI CITY 11073
- **STATE:** F5
- **ZIP:** 5F-4
- **BUSINESS PHONE:** 886277137952

**MAIL ADDRESS:**
- **STREET 1:** NO.89, SONGREN RD., XINYI DIST.
- **CITY:** TAIPEI CITY 11073
- **STATE:** F5
- **ZIP:** 5F-4

### UNITED STATES SECURITIES AND EXCHANGE COMMISSION
**Washington, D.C. 20549**

## SCHEDULE 13G

### Under the Securities Exchange Act of 1934

**(Amendment No. 2)**

**Issuer:** Apollomics Inc.

**Title of Class of Securities:** Class A ordinary shares, Par Value $0.0001 per share

**CUSIP Number:** G0411D123

**Date of Event Which Requires Filing of this Statement:** 09/03/2025

**Check the appropriate box to designate the rule pursuant to which this Schedule is filed:**

- [x] Rule 13d-1(b)

- [ ] Rule 13d-1(c)

- [ ] Rule 13d-1(d)

---

| 1. | Names of Reporting Persons<br>Maxpro Investment Co., Ltd | Names of Reporting Persons<br>Maxpro Investment Co., Ltd |
|:---|:---|:---|:---|
| 2. | Check the Appropriate Box if a Member of a Group (See Instructions)<br>(a) [ ] (b) [ ] | Check the Appropriate Box if a Member of a Group (See Instructions)<br>(a) [ ] (b) [ ] |
| 3. | SEC Use Only | SEC Use Only |
| 4. | Citizenship or Place of Organization<br>E9 | Citizenship or Place of Organization<br>E9 |
| Number of<br>Shares<br>Beneficially<br>Owned by<br>Each<br>Reporting<br>Person<br>With | 5. | Sole Voting Power<br>105071.00 |
| Number of<br>Shares<br>Beneficially<br>Owned by<br>Each<br>Reporting<br>Person<br>With | 6. | Shared Voting Power<br>0.00 |
| Number of<br>Shares<br>Beneficially<br>Owned by<br>Each<br>Reporting<br>Person<br>With | 7. | Sole Dispositive Power<br>105071.00 |
| Number of<br>Shares<br>Beneficially<br>Owned by<br>Each<br>Reporting<br>Person<br>With | 8. | Shared Dispositive Power<br>0.00 |
| 9. | Aggregate Amount Beneficially Owned by Each Reporting Person<br>105071.00 | Aggregate Amount Beneficially Owned by Each Reporting Person<br>105071.00 |
| 10. | Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions) [ ] | Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions) [ ] |
| 11. | Percent of Class Represented by Amount in Row (9)<br>4.90% | Percent of Class Represented by Amount in Row (9)<br>4.90% |
| 12. | Type of Reporting Person (See Instructions)<br>FI | Type of Reporting Person (See Instructions)<br>FI |

---

**Item 1(a). Name of Issuer:**
Apollomics Inc.

**Item 1(b). Address of Issuer's Principal Executive Offices:**
989 E. Hillsdale Blvd., Suite 220, Foster City, CA, 94404, United States of America

**Item 2(a). Name of Person Filing:**
Maxpro Investment Co. Ltd (the "Reporting Person")

**Item 2(b). Address of Principal Business Office:**
5F-4, No.89, Songren Rd., Xinyi District., Taipei City, Taiwan 11073

**Item 2(c). Citizenship:**
Cayman Islands

**Item 2(d). Title of Class of Securities:**
Class A ordinary shares, Par Value $0.0001 per share

**Item 2(e). CUSIP Number:**
G0411D123

**Item 3. If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:**

(a) [ ] Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o).

(b) [ ] Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c).

(c) [ ] Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c).

(d) [ ] Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8).

(e) [ ] An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);

(f) [ ] An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);

(g) [ ] A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);

(h) [ ] A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);

(i) [ ] A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);

(j) [ ] A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J), if filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J), please specify the type of institution:

(k) [ ] Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).

**Item 4. Ownership:**

**(a) Amount beneficially owned:**

Explanatory Note:
The Statement on Schedule 13G originally filed with the Securities and Exchange Commission on May 20, 2024, as amended by Amendment No. 1 filed on May 30, 2024, is hereby amended and supplemented by this Amendment No. 2 (this "Amendment").
As of the date of this filing, the Reporting Person may be deemed to beneficially own 105,071 Class A Ordinary Shares, consisting of (i) 101,248 Class A Ordinary Shares and (ii) 3,823 Class A Ordinary Shares issuable upon exercise of warrants exercisable within 60 days of the date of this filing.
As reported on Form 6-K filed by the Issuer, on September 3, 2025, the Issuer issued 1,042,803 Class A Ordinary Shares in a private placement with certain qualified institutional buyers and accredited investors.
As a result of such private placement, the Reporting Person ceased to be the beneficial owner of more than 5 percent of the Issuer's Class A Ordinary Shares. Accordingly, this Amendment constitutes an exit filing for the Reporting Person.
The information required by Items 4(a)-(c), as of the date hereof, is set forth in Rows 5-11 of the cover page hereto for the Reporting Person and is incorporated herein by reference for the Reporting Person.

**(b) Percent of class:**

The information required by Items 4(a)-(c), as of the date hereof, is set forth in Rows 5-11 of the cover page hereto for the Reporting Person and is incorporated herein by reference for the Reporting Person.
The percentages used herein are calculated based upon 2,146,151 Class A Ordinary Shares issued and outstanding as of the date of this filing.  On April 3, 2025, the Issuer had 1,103,348 Class A Ordinary Shares issued and outstanding, as reported in the Issuer's Form 20-F, filed with the Securities and Exchange Commission on April 3, 2025. As reported on Form 6-K filed by the Issuer on September 3, 2025, the Issuer issued 1,042,803 Class A Ordinary Shares in a private placement with certain qualified institutional buyers and accredited investors.

**(c) Number of shares as to which the person has:**

**(i) Sole power to vote or to direct the vote:**

The information required by Items 4(a)-(c), as of the date hereof, is set forth in Rows 5-11 of the cover page hereto for the Reporting Person and is incorporated herein by reference for the Reporting Person.

**(ii) Shared power to vote or to direct the vote:**

The information required by Items 4(a)-(c), as of the date hereof, is set forth in Rows 5-11 of the cover page hereto for the Reporting Person and is incorporated herein by reference for the Reporting Person.

**(iii) Sole power to dispose or to direct the disposition of:**

The information required by Items 4(a)-(c), as of the date hereof, is set forth in Rows 5-11 of the cover page hereto for the Reporting Person and is incorporated herein by reference for the Reporting Person.

**(iv) Shared power to dispose or to direct the disposition of:**

The information required by Items 4(a)-(c), as of the date hereof, is set forth in Rows 5-11 of the cover page hereto for the Reporting Person and is incorporated herein by reference for the Reporting Person.

**Item 5. Ownership of Five Percent or Less of a Class.**

[ ] If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following.

**Item 6. Ownership of More than 5 Percent on Behalf of Another Person.**

Not Applicable

**Item 7. Identification and Classification of the Subsidiary**

Not Applicable

**Item 8. Identification and Classification of Members of the Group**

Not Applicable

**Item 9. Notice of Dissolution of Group**

Not Applicable

**Item 10. Certification:**

By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under ?? 240.14a-11.

By signing below I certify that, to the best of my knowledge and belief, the foreign regulatory scheme applicable to an investment company is substantially comparable to the regulatory scheme applicable to the functionally equivalent U.S. institution(s). I also undertake to furnish to the Commission staff, upon request, information that would otherwise be disclosed in a Schedule 13D.

### SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

**Maxpro Investment Co., Ltd**

**Date:** 09/05/2025

**By:** /s/ Yi Kuei Chen

**Name & Title:** Yi Kuei Chen / Director